News Sofinnova adds a digital medicine string to its VC bow Life sciences venture capital company Sofinnova has launched a new strategy in digital medicine, accompanied by a series of investments in start-ups operating within the c
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.